Article
Toward liquid biopsies in cancer treatment: application of circulating tumor DNA
19 Feb 2019
Abstract excerpt
Circulating tumor DNA (ctDNA) refers to the fraction of cell-free DNA in a patient's blood originating from tumor cells. Increased knowledge about tumor genomics, improvements in targeted therapies, and accompanying advances in DNA-sequencing technologies have increased the interest in using ctDNA as a minimally invasive tool in cancer diagnostics and treatment. Especially, early tumor detection including...
Topics
Join the communities discussing this publication.